Skip to main content
. 2012 May;7(5):748–756. doi: 10.2215/CJN.12901211

Table 3.

Detailed results from subjects with dense deposit disease

Week DDD1 DDD2 DDD3
Scr UPCR Salb C3a C4b CH50c Scr UPCR Salb C3a C4b CH50c Scr UPCR Salb C3a C4b CH50c
0 1.8 0.326 4.6 35 20 32 2.1 2.413 3.6 27 35 44 1.2 5.933 4.2 67 28 49
4 1.5 0.287 4.5 17 15 0 2.2 4.279 3.6 25 28 1 1.2 10.580 2.9 122 35
8 1.6 0.148 4.7 19 20 0 2.3 4.876 3.6 40 46 1 1.6 5.710 3.8 124 31 4
12 1.5 0.317 4.6 21 19 1 1.9 4.152 3.3 27 33 1 1.6 2.480 4.1 119 36 6
16 1.4 0.240 4.4 22 19 0 2.1 5.607 3.0 28 31 2 1.6 2.829 4.5 106 35 2
20 1.5 0.176 4.6 17 17 0 2.2 5.580 3.1 33 40 5 1.4 3.189 4.0 105 28 2
24 1.4 0.290 4.3 23 21 1 2.5 4.948 3.0 25 35 3 1.6 1.417 4.1 115 33 1
28 1.3 0.442 4.5 24 21 1 2.2 3.4 29 33 1 1.6 0.897 4.3 101 29 0
32 1.3 0.663 4.2 25 22 0 2.4 7.707 3.1 34 32 4 1.4 1.270 4.2 89 24 1
36 1.5 0.592 4.2 23 20 4 2.8 6.167 3.2 29 36 1 1.8 1.391 4.6 96 30 3
40 1.4 0.845 4.1 23 25 1 2.9 4.786 3.0 31 27 2 1.7 1.373 4.2 95 32 1
44 1.4 0.381 4.1 20 20 1 1.5 1.917 3.9 112 29 4
48 1.3 0.548 4.0 20 18 0 1.6 0.214 4.2 105 29 3
52 1.4 0.586 4.2 23 22 2 1.7 1.763 4.0 93 28 1

DDD, dense deposit disease; Scr, serum creatinine (mg/dl); UPCR, urine protein to creatinine ratio (g/g); Salb, serum albumin (g/dl).

a

C3 reference range=83–177.

b

C4 reference range=16–47.

c

CH50 reference range=60–144.